118 594

Cited 13 times in

Inter-alpha-trypsin inhibitor heavy chain H4 as a diagnostic and prognostic indicator in patients with hepatitis B virus-associated hepatocellular carcinoma

Authors
Noh, CK | Kim, SS  | Kim, DK | Lee, HY | Cho, HJ  | Yoon, SY | Lee, GH | Hyun, SA | Kim, YJ | Kim, HJ | Hwang, JA | Ahn, SJ  | Shin, SJ  | Lee, KM  | Yoo, BM  | Cho, SW  | Cheong, JY
Citation
Clinical biochemistry, 47(13-14). : 1257-1261, 2014
Journal Title
Clinical biochemistry
ISSN
0009-91201873-2933
Abstract
OBJECTIVES: Inter-alpha-trypsin inhibitor heavy chain H4 (ITIH4) is associated

with various diseases. We evaluated the diagnostic and prognostic significance of

serum ITIH4 levels in healthy controls and patients with chronic hepatitis B

(CHB), hepatitis B virus (HBV)-related liver cirrhosis, and HBV-related

hepatocellular carcinoma (HCC). DESIGN AND METHODS: The study enrolled 300

individuals (50 healthy controls, 50 with CHB, 100 with HBV-associated cirrhosis,

and 100 with HBV-associated HCC). Serum ITIH4 levels were determined by western

blot analysis and expressed in densitometry units (DU). RESULTS: ITIH4 levels

were higher in CHB (mean: 252.96 DU) and liver cirrhosis (mean: 206.43 DU)

patients than in healthy controls (mean: 75.92 DU) and HCC patients (mean: 92.86

DU) (P<0.001). The area under the receiver operating characteristic curve was

0.71 for the diagnosis of HCC in patients with HBV-related liver disease.

Multivariate Cox regression analysis showed that large tumor size (>/=5 cm) was

independently associated with overall survival (hazard ratio 5.894, 95%

confidence interval 1.373-25.300, P=0.017). A Kaplan-Meier survival analysis

showed significantly worse survival among HCC patients with both low ITIH4 (<80

DU) and a large tumor size compared to that among other HCC patients (P<0.001),

and among patients with high AFP (>200 ng/mL) and low ITIH4 compared to that

among other HCC patients (P=0.041). CONCLUSIONS: Serum ITIH4 levels are reduced

in HCC patients compared to that in CHB and cirrhosis patients, and low serum

ITIH4 levels are associated with shorter survival in HBV-associated HCC patients.
MeSH

DOI
10.1016/j.clinbiochem.2014.05.002
PMID
24836184
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Gastroenterology
Ajou Authors
김, 순선  |  신, 성재  |  안, 선주  |  유, 병무  |  이, 기명  |  정, 재연  |  조, 성원  |  조, 효정
Full Text Link
Files in This Item:
24836184.pdfDownload
Export

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse